During the past decade, Center for Sight conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Center for Sight" #1 sponsor was "AMO Development, LLC" with 1 trials, followed by "Alcon Research" with 1 trials sponsored, "CORD, LLC" with 1 trials sponsored, "Formosa Pharmaceuticals, Inc." with 1 trials sponsored and "Glaukos Corporation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "Center for Sight" are "Cataract" (2 trials), "Aphakia" (1 trials), "Corneal Edema After Cataract Surgery" (1 trials), "Glaucoma, Open-Angle" (1 trials) and "Ocular Hypertension" (1 trials). Many other conditions were trialed in "Center for Sight" in a lesser frequency.

Most popular intervention types in "Center for Sight" are "Device" (4 trials), "Drug" (3 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "APP13007, 0.05%" (1 trials), "Cataract surgery" (1 trials), "Control IOL" (1 trials), "G2TR intraocular implant containing travoprost" (1 trials) and "Hydrus Microstent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center for Sight" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Center for Sight". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Center for Sight, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Center for Sight, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".